EUVIMEDEUVIMED entdecken
Crossref

Identification and characterization of a novel ergothioneine conjugate of raloxifene

Abhijith Rao, Sivaprasad Putluru, Prasanth Eapen, Hemantha Kumar, Raviraj Landge, Khemraj Bairwa, Srikanth Sridhar, T Thanga Mariappan, Michael Sinz, Prakash Vachaspati

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2024.100034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Abhijith Rao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center, Syngene International Limited, Bengaluru, Karnataka, India. Electronic…. Hauptthemen laut MEDLINE: Ergothioneine, Raloxifene Hydrochloride. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgothioneineRaloxifene HydrochlorideAnimalsRatsMicrosomes, LiverHumansDogsMiceMaleHepatocytesRats, Sprague-DawleyGlutathioneHaplorhini

Stichwörter der Autor:innen

BioactivationConjugationGlutathioneL-ErgothioneineRaloxifene

Substanzen

ErgothioneineRaloxifene HydrochlorideGlutathione

Autor:innen und Institutionen

  • Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center, Syngene International Limited, Bengaluru, Karnataka, India. Electronic address: abhijith.rao@syngeneintl.com.
  • Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center, Syngene International Limited, Bengaluru, Karnataka, India.
  • Discovery Analytical Sciences, Biocon Bristol Myers Squibb R&D Center, Syngene International Limited, Bengaluru, Karnataka, India.
  • Bio-Pharmaceutics, Biocon Bristol Myers Squibb R&D Center, Syngene International Limited, Bengaluru, Karnataka, India.
  • Pharmaceutical Candidate optimization, Bristol Myers Squibb Company, Biocon Bristol Myers Squibb R&D Center, Bengaluru, Karnataka, India.
  • Pharmaceutical Candidate optimization, Bristol Myers Squibb Company, Lawrenceville, New Jersey.

Zitieren

APA

Rao, A., Putluru, S., Eapen, P., Kumar, H., Landge, R., Bairwa, K., Sridhar, S., Mariappan, T. T., Sinz, M., & Vachaspati, P. (2025). Identification and characterization of a novel ergothioneine conjugate of raloxifene. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2024.100034

Vancouver

Rao A, Putluru S, Eapen P, Kumar H, Landge R, Bairwa K, et al. Identification and characterization of a novel ergothioneine conjugate of raloxifene. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2024.100034

BibTeX
@article{Rao2025,
  author = {Rao, Abhijith and Putluru, Sivaprasad and Eapen, Prasanth and Kumar, Hemantha and Landge, Raviraj and Bairwa, Khemraj and Sridhar, Srikanth and Mariappan, T Thanga and Sinz, Michael and Vachaspati, Prakash},
  title = {Identification and characterization of a novel ergothioneine conjugate of raloxifene},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2024.100034}
}
Kostenlos starten →